Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening
NCT ID: NCT05710757
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2023-10-16
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Lower Extremity Blood Flow Restriction Training on Power, and Muscle Size.
NCT03983070
Eccentric Resistance Training With Blood Flow Restriction on Muscle Function
NCT04977804
Low Resistance Venous Blood Flow Restriction Training (LR-VBFRT) on Biceps Brachii Muscle Performance
NCT04181671
BFR and Muscle Mitochondrial Oxidative Capacity
NCT03723226
The Effects of Restriction Pressure on Muscle Damage Responses to Blood Flow Restriction Exercise
NCT05037942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myofascial Release
The Experimental group will receive a myofascial release pectoralis minor release intervention.
myofascial release
Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.
blood flow restriction
Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response.
Sham Myofascial Release
The Control group will receive a sham myofascial release pectoralis minor release intervention.
blood flow restriction
Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response.
myofascial release
Sham MFR.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
myofascial release
Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.
blood flow restriction
Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response.
myofascial release
Sham MFR.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Individuals with sickle cell anemia, current pregnancy
* Individuals with a history of deep vein thrombosis
* Individuals with diabetes
* Individuals with active infection
* Individuals with less than normal range of motion or muscle strength
* Individuals with moderate to severe upper extremity injury in the past 12 months
* Individuals with a current diagnosis of cancer.
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Tennessee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LaToya Green
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Tennessee Health Science Center
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-08926-XP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.